Eloxx Pharmaceuticals, Inc. (ELOX) Max Pain Analysis
Max pain is the strike price where aggregate option buyer payout is minimized at expiration. It represents the price at which option writers retain the most premium.
Eloxx Pharmaceuticals, Inc. (ELOX) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $95.3M, listed on NASDAQ, employing roughly 10 people, carrying a beta of -24.60 to the broader market. Eloxx Pharmaceuticals is a clinical-stage biopharmaceutical firm that specializes in developing therapeutic solutions through ribosome modulation. Led by Sumit Aggarwal, public since 2026-06-09.
Max pain analysis shows the strike price where the most options expire worthless. No recent options activity for ELOX as of 2026-07-17; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.